| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 373.29B | 350.51B | 301.07B | 307.52B | 215.36B | 362.87B |
| Gross Profit | 16.51B | 20.09B | 16.35B | 18.90B | 10.45B | 15.89B |
| EBITDA | 19.54B | 14.92B | 7.01B | 11.61B | 4.45B | 8.86B |
| Net Income | 6.10B | 3.03B | 407.00M | 3.88B | -2.22B | 1.92B |
Balance Sheet | ||||||
| Total Assets | 260.93B | 272.67B | 260.47B | 250.43B | 232.53B | 262.37B |
| Cash, Cash Equivalents and Short-Term Investments | 90.11B | 93.06B | 41.41B | 49.43B | 52.87B | 125.78B |
| Total Debt | 2.86B | 17.15B | 24.67B | 2.27B | 4.06B | 4.43B |
| Total Liabilities | 83.68B | 96.11B | 86.13B | 77.44B | 60.34B | 87.19B |
| Stockholders Equity | 177.25B | 176.56B | 174.33B | 172.99B | 172.19B | 175.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.01B | -4.83B | 988.00M | 3.41B | 4.65B |
| Operating Cash Flow | 0.00 | 9.00B | 7.69B | 10.98B | 7.87B | 8.24B |
| Investing Cash Flow | 0.00 | 59.10B | -12.11B | -9.30B | -75.16B | -481.00M |
| Financing Cash Flow | 0.00 | -16.46B | -3.59B | -5.12B | -5.63B | -5.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥1.64T | 8.25 | ― | 3.74% | -5.66% | -28.73% | |
68 Neutral | ¥43.41T | 8.70 | 12.89% | 2.78% | 6.44% | 11.88% | |
66 Neutral | ¥464.53B | 26.18 | -0.65% | 3.33% | -0.87% | -105.50% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥661.36B | 6.29 | 1.72% | 4.52% | -0.83% | -75.20% | |
54 Neutral | ¥136.81B | 19.38 | ― | 1.29% | 28.98% | ― | |
47 Neutral | ¥1.24T | -12.05 | -16.69% | ― | -3.01% | -755.71% |